Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide

American Journal of Kidney Diseases

Volumn 32, Issue 2, 1998, Pages 318-322

  Glicklich, Daniel ^a   Acharya, Anjali ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Cyclophosphamide; Lupus nephritis; Mycophenolate mofetil

Indexed keywords

CYCLOPHOSPHAMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ARTICLE; CASE REPORT; FEMALE; GLOMERULONEPHRITIS; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

EID: 0031880581     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.1998.v32.pm9708620     Document Type: Article

References (15)

1. Austin HA, Klippel JH, Balow JE, Le Riche NGH, Steinberg AD, Plotz PH, Decker JL: Therapy of lupus nephritis-controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314:614-619, 1986
2. Steinberg AD, Steinberg SC: Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone alone. Arthritis Rheum 34:945-949, 1991
3. Gourley MF, Austin HA, Scott D, Yarboro CH, Vaughn EM, Muir J, Boumpas DT, Klippel JH, Balow JE, Steinberg AD: Methylprednisolone and cyclophosphamide, alone or in combination in patients with lupus nephritis. Ann Intern Med 125:549-557, 1996
4. Dooley MA, Hogan S, Jennette C, Falk R: Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans. Kidney Int 51:1188-1195, 1997
5. Berden JHM: Lupus nephritis. Kidney Int 52:538-558, 1997
6. Corna D, Morigi M, Facchinetti D, Bertani T, Zoja C, Remuzzi G: Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease. Kidney Int 51:1583-1589, 1997
7. Sollinger HW: Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 60:225-232, 1995
8. Danovitch G: Mycophenolate mofetil for the treatment of refractory acute cellular renal transplant rejection. Transplantation 61:722-729, 1996
9. Goldblum R: Therapy of rheumatoid arthritis with mycophenolate mofetil. Clin Exp Rheumatol 11:5117-5119, 1993
10. Hebert LA, Cosio FG, Bay WH, Hernandez R, Lautman J: Mycophenolate mofetil therapy of systemic lupus erythematosus and ANCA vasculitis. J Am Soc Nephrol 8:87A, 1997 (abstr)
11. Nachman PH, Dooley MA, Hogan SL, Aiello JR, Jennette JC, Falk RJ: Mycophenolate mofetil therapy in patients with cyclophosphamide-resistant or relapsing diffuse proliferative lupus nephritis. J Am Soc Nephrol 8:94A, 1997 (abstr)
12. Briggs WA, Choi MJ, Scheel PJ: Successful mycophenolate mofetil treatment of glomerular disease. Am J Kidney Dis 31:213-217, 1998
13. Raisanen-Sokolowski A, Vuoristo P, Myllarnierni M, Yilmaz S, Kallio E, Hayry P: Mycophenolate mofetil inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts. Transplant Immunol 3:342-352, 1995
14. Boumpas DT, Austin HA, Vaughn EM, Klippel JH, Steinberg AD, Yarboro CH, Balow JE: Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 340:741-745, 1992
15. Kiberd B, MacDonald A: Mycophenolate and glomerular disease. Am J Kidney Dis 31:364-365, 1998